1. Volume 148, Issue 3, Pages 537-546.e4 (March 2015)
Quantitative Gastrointestinal and Psychological Traits Associated With Obesity and Response to Weight-Loss Therapy 
Andres Acosta, Michael Camilleri, Andrea Shin, Maria I. Vazquez-Roque, Johanna Iturrino, Duane Burton, Jessica O’Neill, Deborah Eckert, Alan R. Zinsmeister 
Gastroenterology 
Volume 148, Issue 3, Pages e4 (March 2015)
DOI: /j.gastro
Copyright © 2015 AGA Institute Terms and Conditions

2. Figure 1
Upper panel: Relationship of kilocalorie intake at prior ad libitum meal and kilocalorie intake in response to randomized treatment; note that there are significant associations in both treatment groups. Lower panel: Association of change in body weight (in response to randomized treatment with placebo or phentermine-topiramate-ER) and kilocalorie intake at prior ad libitum meal. Note the kilocalorie intake at baseline before treatment is associated with the degree of weight loss on treatment with phentermine-topiramate-ER with no observed effect with placebo treatment. This is illustrated by P = .029 for the drug treatment interaction.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2015 AGA Institute Terms and Conditions

3. Supplementary Figure 1
CONSORT (Consolidated Standards of Reporting Trials) flow chart for randomized controlled trial of effects of phentermine-topiramate-ER on weight loss and quantitative traits in obesity.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2015 AGA Institute Terms and Conditions

4. Supplementary Figure 2
Study protocol for randomized controlled trial of effects of phentermine-topiramate-ER on weight loss and quantitative traits measured on days 12 to 14 of treatment.
Gastroenterology  , e4DOI: ( /j.gastro )
Copyright © 2015 AGA Institute Terms and Conditions